Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v5-EN
Language English English
Date Updated 2022-08-02 2022-08-02
Drug Identification Number 02230417 02230417
Brand name HEMABATE HEMABATE
Common or Proper name HEMABATE HEMABATE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CARBOPROST CARBOPROST
Strength(s) 250MCG 250MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 1mL amp 10 x 1mL amp
ATC code G02AD G02AD
ATC description UTEROTONICS UTEROTONICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-13 2022-07-13
Estimated end date 2022-08-15 2022-08-15
Actual end date 2022-08-01 2022-08-01
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments